TSX Penny Stocks To Watch In August 2026

Cooling inflation and a steady economic backdrop have provided a supportive environment for Canadian markets, with major indexes reaching new highs. As investors navigate these conditions, penny stocks continue to offer intriguing opportunities despite being considered somewhat outdated. These smaller or newer companies can present significant growth potential when they possess strong financials, and we’ve identified three such stocks that stand out for their balance sheet strength and potential upside.

Underneath we present a selection of stocks filtered out by our screen.

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Pharmala Biotech Holdings Inc. is a biotechnology company focused on developing, manufacturing, and selling MDMA and MDXX class molecules for the clinical research community, with a market cap of CA$20.21 million.

Operations: Pharmala Biotech Holdings generates revenue of CA$1.27 million from its MDMA and MDXX class molecules segment.

Market Cap: CA$20.21M

Pharmala Biotech Holdings Inc., with a market cap of CA$20.21 million, is navigating the volatile penny stock landscape with strategic moves in its MDMA and MDXX class molecules segment. Despite generating CA$1.27 million in revenue, it remains pre-revenue by broader industry standards. Recent developments include a licensing agreement with Jupiter Neurosciences for ALA-002, potentially worth up to US$100 million contingent on milestones and royalties. Pharmala’s successful GMP manufacturing completion and Australian patent acquisition underscore its operational progress, but the company faces challenges with less than a year of cash runway and high share price volatility.

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: GFG Resources Inc. focuses on the acquisition, exploration, and development of mineral properties in Canada, with a market cap of CA$69.97 million.

Operations: GFG Resources Inc. does not report any revenue segments as it is primarily engaged in the acquisition, exploration, and development of mineral properties in Canada.

Market Cap: CA$69.97M

GFG Resources Inc., with a market cap of CA$69.97 million, is actively pursuing exploration opportunities in the Timmins Gold District of Ontario. The company is pre-revenue, focusing on mineral acquisition and development without significant income streams. Recent assay results from its Nahanni drill program revealed high-grade gold mineralization across multiple targets, enhancing the exploration potential of its Goldarm Property. Despite being debt-free and having experienced management, GFG faces financial constraints with less than a year of cash runway based on current free cash flow trends. Shareholder dilution has been minimal over the past year.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Rockhaven Resources Ltd. is an exploration stage company focused on acquiring, exploring, and evaluating mineral properties in Canada, with a market cap of CA$48.31 million.

Operations: Currently, there are no reported revenue segments for this exploration stage company.

Market Cap: CA$48.31M

Rockhaven Resources Ltd., with a market cap of CA$48.31 million, remains pre-revenue as it focuses on mineral exploration and development, particularly at its Klaza Deposit in Yukon. The company recently received government approval to extract high-grade Direct Shipping Oxide material from the site, which is royalty-free and road-accessible. Rockhaven has secured agreements for excavation and transportation, alongside an offtake agreement providing a revolving credit facility up to US$1.5 million. Despite having no debt and seasoned management, Rockhaven faces challenges with long-term liabilities exceeding short-term assets while maintaining over a year of cash runway based on current free cash flow trends.

Seize The Opportunity

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com